Foundation Medicine (FMI) Prelim. Q4 Revenue Tops Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. ZETA
10. DAL

Go back to Foundation Medicine (FMI) Prelim. Q4 Revenue Tops Views

Foundation Medicine Reports Preliminary 2017 Results

January 8, 2018 6:30 AM EST

Reports Total Revenue of Approximately $152.9 Million, a 31% Year Over Year Increase; Reports 67,375 Clinical Tests in 2017, a 54% Year Over Year Increase

Increases Biopharma Revenue Approximately 27% Year-Over-Year with New and Expanded Collaborations

Achieves Significant Milestone with FDA Approval and Preliminary National Coverage Determination (NCD) for FoundationOne CDx

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine (NASDAQ: FMI) today announced... More